Categorization of COVID-19 severity to determine mortality risk.
Garry EM, Weckstein AR, Quinto K, Bradley MC, Lasky T, Chakravarty A, Leonard S, Vititoe SE, Easthausen IJ, Rassen JA, Gatto NM.
Garry EM, et al. Among authors: chakravarty a.
Pharmacoepidemiol Drug Saf. 2022 Jul;31(7):721-728. doi: 10.1002/pds.5436. Epub 2022 May 9.
Pharmacoepidemiol Drug Saf. 2022.
PMID: 35373865
Free PMC article.